中鹽化工(600328.SH):吉鹽化集團已減持394.69萬股 減持期已過半
格隆匯11月5日丨中鹽化工(600328.SH)公佈,本次減持股份計劃實施前,公司控股股東吉鹽化集團持有公司股票5.33億股,佔公司總股本9.58億股的55.69%。
2021年8月28日,公司披露了《中鹽內蒙古化工股份有限公司股東集中競價減持股份計劃公吿》。2021年11月5日,公司收到吉鹽化集團《關於減持計劃時間過半的吿知函》,截至2021年11月5日,本次減持時間已過半。在減持計劃期間內,吉鹽化集團累計減持公司股份394.69萬股,本次減持計劃尚未完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.